je.st
news
Tag: pershing
Tracking Bill Ackman's Pershing Square Portfolio - Q3 2014 Update
2014-11-17 23:05:11| Railroads - Topix.net
This article is part of a series that provides an ongoing analysis of the changes made to Pershing Square's US long portfolio on a quarterly basis. It is based on Ackman's regulatory 13F Form filed on 11/14/2014.
Tags: update
bill
square
portfolio
Ackman's Pershing Square Takes Stake in Drugmaker Zoetis
2014-11-12 07:08:47| Biotech - Topix.net
Bill Ackman 's Pershing Square Capital Management LP acquired an 8.5 percent activist stake in animal drug maker Zoetis Inc. , sending its shares to a record high yesterday. Ackman informed Zoetis of the stake in a phone call, the company said in a statement, without providing further details.
Tags: takes
square
stake
pershing
Pershing Square says Allergan CEO led smear campaign against Valeant
2014-10-22 11:21:16| Biotech - Topix.net
Pershing Square Capital Management says that it has uncovered evidence that the management of Allergan Inc. made false and misleading statements about Valeant Pharmaceuticals Inc. as part of a "scorched earth" campaign to thwart the Canadian company's hostile takeover of the California-based maker of Botox. Pershing Square, which is Allergan's largest shareholder and Valeant's ally in the takeover battle, says in a 44-page court filing - which has many portions blacked out and which hasn't been tested in court - that Allergan chief executive David Pyott, who is also chairman of Allergan's board, "personally led the charge and directed much of the misconduct."
Allergan Inc. (AGN), Canadian Pacific Railway Ltd (CP): Pershing Square Up 25%
2014-07-08 01:31:22| Railroads - Topix.net
While most hedge funds continue to lag the market, having returned an average of only 2% through May, about half of what S&P 500 returned, a few of them have managed to outperform its peers .
Tags: up
square
pacific
canadian
Pershing Square names Allergan board candidates
2014-07-07 21:17:06| Biotech - Topix.net
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International Inc. want to buy Allergan and have offered $72 per share, or about $53 billion in cash and stock, for the company.
Tags: board
names
square
candidates